Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3829 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Simon D Brandt und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. Hauptthemen laut MEDLINE: Lysergic Acid Diethylamide, Hallucinogens, Thiophenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
The classical psychedelic drug (+)‐lysergic acid diethylamide (LSD) continues to attract considerable multidisciplinary interest, and over the last eight decades, many derivatives and analogs of LSD have been synthesized. One site on the ergoline scaffold of LSD that has been frequently modified is the N 1 ‐position, with the N 1 ‐acylated LSD derivative 1‐acetyl‐LSD (1A‐LSD, ALD‐52) being one of the earliest examples. In more recent years, several other alkylcarbonyl‐ and cycloalkylcarbonyl‐substituted LSD derivatives have been evaluated, including several distributed as research chemicals. Although N 1 ‐substitution is detrimental for the activity of LSD at the 5‐HT 2A receptor (the primary site of action of psychedelic drugs), N 1 ‐acylated LSD derivatives are rapidly hydrolyzed in vivo and are believed to act as prodrugs for LSD. Recently, 1‐(thiophene‐2‐carbonyl)‐LSD (1T‐LSD, SYN‐L‐021) was detected as a new recreational drug, signaling a move towards N 1 ‐acyl groups with an aromatic character. The present study was conducted to investigate the analytical profile and pharmacology of 1‐(2‐furoyl)‐lysergic acid diethylamide (1F‐LSD, SYN‐L‐005), a novel analog of 1T‐LSD. The binding of 1F‐LSD to the 5‐HT 2A receptor and other monoamine sites was assessed using radioligand binding. Furthermore, the in vivo activities of 1F‐LSD and 1T‐LSD were assessed in C57BL/6 J mice by comparing their biotransformation to LSD and effects on the head‐twitch response (HTR), a 5‐HT 2A ‐mediated behavior. Both 1F‐LSD and 1T‐LSD induced the HTR in mice and were hydrolyzed to LSD after in vivo administration, indicating that both substances exhibit LSD‐like properties and may serve as prodrugs for LSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
- Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin 8, Ireland.
- Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, UK.
- Elliott Forensic Consulting, Birmingham, UK.
- Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK.
- Synex Synthetics BV, Maastricht, The Netherlands.
ORCID-Profile: Simon D Brandt, Pierce V Kavanagh, Sarah Gare, Simon P Elliott, Adam L Halberstadt
Förderung
- NIDA NIH HHS
Zitieren
APA
Brandt, S. D., Kavanagh, P. V., Gare, S., Elliott, S. P., Stratford, A., & Halberstadt, A. L. (2025). Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD). Drug Testing and Analysis. https://doi.org/10.1002/dta.3829
Vancouver
Brandt SD, Kavanagh PV, Gare S, Elliott SP, Stratford A, Halberstadt AL. Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD). Drug Testing and Analysis. 2025. doi:10.1002/dta.3829
BibTeX
@article{Brandt2025,
author = {Brandt, Simon D and Kavanagh, Pierce V and Gare, Sarah and Elliott, Simon P and Stratford, Alexander and Halberstadt, Adam L},
title = {Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3829}
}
EUVIMED